Look into Hepatic Progenitor Cell Associated Trait:Histological Heterogeneity of Hepatitis B-Related Combined Hepatocellular-Cholangiocarcinoma

Combined hepatocellular-cholangiocarcinoma(CHC) is a mixed tumor containing elements of both hepatocellular carcinoma(HCC) and cholangiocarcinoma(CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell(HPC) origin. However, detailed histological or phenotyp...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 37; no. 6; pp. 873 - 879
Main Author 蔡雄;熊俊;胡青钢;赵秋东;吴东;唐礼功;万赤丹;卫立辛
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.12.2017
Department of Hepatobiliary Surgery,Union Hospital Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China%Tumor Immunology and Gene Therapy Center,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai200438,China%Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai200438,China%Department of Urology,Wuhan General Hospital of PLA,Wuhan 430070,China
Subjects
Online AccessGet full text
ISSN1672-0733
2096-5230
1993-1352
1993-1352
2523-899X
DOI10.1007/s11596-017-1820-y

Cover

Loading…
More Information
Summary:Combined hepatocellular-cholangiocarcinoma(CHC) is a mixed tumor containing elements of both hepatocellular carcinoma(HCC) and cholangiocarcinoma(CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell(HPC) origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7(K7) staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the "transitional" cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of "stemness" by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.
Bibliography:human cholangiohepatoma progenitor heterogeneity histology
42-1679/R
Combined hepatocellular-cholangiocarcinoma(CHC) is a mixed tumor containing elements of both hepatocellular carcinoma(HCC) and cholangiocarcinoma(CC). Its remarkable histological heterogeneity has been linked to putative hepatic progenitor cell(HPC) origin. However, detailed histological or phenotypic description is rarely documented. In the present study, we reassessed 68 cases previously diagnosed as hepatitis B-related CHCs by immunohistochemistry and double-fluorescence immunostaining, focusing on HPC associated phenotypic observation of intermediate area of the tumor. It was found that tumor cells showed remarkable heterogeneity in intermediate area. Tumor cells with intermediate morphology between hepatocytes and cholangiocytes were oval-shaped and small with scant cytoplasm and hyperchromatic nuclei, arranging in solid nests mostly. By Keratin 7(K7) staining, it appeared that the nests of tumor cells represented a maturation process from the undifferentiated small cells to mature hepatocytes through the "transitional" cells. Then, these small cells were further confirmed with intermediate phenotype as HPC by exploring immature hepatocellular marker and HPC/biliary markers co-localization. In conclusion, the HPC associated trait in CHC can be interpreted by HPC origin or gain of "stemness" by dedifferentiation. It is still too soon to give a final word that it is innate or acquired signature of HPC associated trait in CHC.
Xiong CAI , Jun XIONG , Qing-gang HU , Qiu-dong ZHAO , Dong WU Li-gong TANG , Chi-dan WAN , Li-xin WEI (1Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China 2Tumor Immunology and Gene Therapy Center, 3Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai200438, China 4Department of Urology, Wuhan General Hospital of PLA, Wuhan 430070, China)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-0733
2096-5230
1993-1352
1993-1352
2523-899X
DOI:10.1007/s11596-017-1820-y